{"filings":[{"id":692876,"accession_number":"0001493152-26-025377","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2026-05-27T19:00:23+00:00","items":["3.01"],"status":"ready","headline":"SINTX Technologies receives Nasdaq delisting notice for insufficient stockholders' equity","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on May 22, 2026 for non-compliance with minimum $2.5M stockholders' equity; reported equity ~$904k.","Also fails alternative listing standards based on market value or net income.","Has 45 days until July 6, 2026 to submit compliance plan; may get up to 180-day extension.","Pursuing equity financing and strategic initiatives to regain compliance; no assurance of success.","Nasdaq listing and trading not immediately affected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":"2026-05-27","daily_digest_url":"/daily/2026-05-27","daily_digest_rank":3},{"id":102193,"accession_number":"0001493152-26-007271","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2026-02-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SINTX appoints Ryan Elmore as President, Eric Olson steps down from role effective March 16","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric Olson ceases as President but remains Chairman and CEO; Ryan Elmore appointed President.","Elmore employment agreement: $375,000 base salary, 35% target annual bonus, $100,000 sign-on bonus.","Initial RSU grant valued at $300,000: 20% vests on grant date, 80% over 24 months.","Severance: 2x base salary plus target bonus if terminated without cause or for good reason.","Enhanced severance upon change in control: 2x base salary plus target bonus within 1 year of CIC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118514,"accession_number":"0001493152-25-025496","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-12-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SINTX signs supply agreement with Evonik for SiN/PEEK compound for 3D-printed implants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Evonik Corporation will manufacture SINTX's proprietary SiN/PEEK compound (U.S. Patent No. 10,806,831) at commercial scale.","Enables immediate production of AI-assisted, 3D-printed patient-specific implants for humanitarian-use vertebral body replacement (VBR) cases.","SINTX has received physician requests for VBR implants for orthopedic and neurosurgical oncology patients post-tumor resection.","SiN/PEEK offers antipathogenic surface behavior, osteogenic support, and improved visualization vs. standard PEEK."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118513,"accession_number":"0001493152-25-022125","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SINTX Q3 2025 net loss narrows to $3.5M; FDA clearance for SINAPTIC wedge system","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss of $3.5M ($1.19 per share) vs $6.2M ($6.96 per share) in Q3 2024.","Revenue of $0.2M, down from $0.8M YoY due to lower grant revenue; operating expenses decreased 51% to $3.4M.","Cash rose to $6.25M from $3.60M at Dec 2024; raised $4.3M through warrant exercises.","FDA 510(k) clearance for SINAPTIC Foot & Ankle Osteotomy Wedge System; first commercial revenue from OsseoSculpt recorded."],"consensus_eps_estimate":null,"consensus_eps_actual":-6.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":728000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118512,"accession_number":"0001493152-25-016904","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"SINTX Technologies enters $6.4M ATM equity offering agreement with H.C. Wainwright","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aggregate offering price up to $6,413,876; commission rate 3.0% of gross proceeds.","Sales agent H.C. Wainwright to sell shares at-the-market on Nasdaq Capital Market.","Company may suspend or terminate offering at any time; no minimum sales obligation.","Shares issued under effective shelf registration statement (File No. 333-274951)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134972,"accession_number":"0001493152-25-012834","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-09-09T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"SINTX raises ~$3.8M via warrant exercise inducement; issues new warrants at $4.79 strike","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Inducement agreement with holders to exercise 1,099,431 existing warrants at $3.32/share for cash.","Gross proceeds ~$3.8M; new warrants issued for 1,649,147 shares at $4.79, 5.5-year term.","Placement agent H.C. Wainwright receives 7.5% cash fee and warrants; closing expected Sept 9, 2025.","Post-closing share count rises from 2,850,957 to 3,950,388.","Proceeds for general corporate purposes; resale registration to be filed within 30 days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134971,"accession_number":"0001493152-25-012731","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"SINTX appoints Kevin Trask as CFO; salary $300K, RSUs, bonus eligibility","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin Trask appointed CFO effective September 4, 2025; salary set at $300,000 annually.","Trask eligible for discretionary bonus up to 35% of salary; receives 20,000 RSUs (20% immediate vest, 20% every 6 months).","Trask previously Corporate Controller at SINTX since May 2025; prior roles at USANA and Quotient.","Stockholders approved 2025 Equity Incentive Plan; also ratified auditor and approved executive compensation.","Directors Robert Mitchell and Chris Lyons re-elected; all five proposals passed at annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134970,"accession_number":"0001641172-25-020513","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SINTX submits FDA 510(k) for silicon nitride foot/ankle implants, entering $750M market","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Filed 510(k) for silicon nitride osteotomy wedges on July 22, 2025, targeting foot/ankle fusion.","Foot/ankle fusion market valued at $750.5M, projected to reach $1.38B by 2032.","Biomaterial track record: >50,000 spinal implants since 2008; antimicrobial & radiolucent properties.","Implants to be manufactured at SINTX's FDA/ISO facility, distributed as SiNAPTIC Surgical (acquired July 1, 2025).","Expected to drive revenue growth through hospital and ASC adoption with single-use instrumentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151919,"accession_number":"0001641172-25-016891","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-06-27T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"SINTX acquires SiNAPTIC Surgical assets for $750K in stock plus warrants; enters foot/ankle fusion market","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all IP and designs for six foot/ankle implant systems; market valued at $750M growing to $1.38B by 2032.","Consideration: $750K in common shares at $3.465 (10% premium) plus 325,000 performance-based warrants exercisable at $6.30.","Warrants vest upon FDA clearance and cumulative revenue milestones up to $15M; also 5% royalty after $15M.","Key SiNAPTIC executives join SINTX: Dr. Bryan Scheer leads Clinical Advisory Board, plus others in commercial and regulatory roles.","Expected closing July 1, 2025; SINTX will manufacture under its existing FDA-registered and ISO-certified quality system."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151918,"accession_number":"0001641172-25-011981","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SINTX obtains international patent for Si₃N₄ agribiotech use; forms Agribiotech subsidiary","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["International Patent No. 7635292 covers agricultural uses of silicon nitride (Si₃N₄) for plant protection and antimicrobial treatment.","Wholly-owned subsidiary SINTX Agribiotech, Inc. formed with dedicated management team to commercialize agri/enviro technologies.","Global antimicrobial fertilizer & crop protection market projected to reach $10.36B by 2030; Si₃N₄ targets sustainability.","Silicon nitride reduced grapevine downy mildew (P. viticola) growth by 80-90% in trials, with complete protection in select cases.","Subsidiary operates independently from medical device business, enabling focused resource allocation and partnerships."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151917,"accession_number":"0001641172-25-010503","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SINTX refocuses on medical devices; Q1 cash doubles to $6.5M, cash burn halved","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Cash on hand $6.5M at March 31, 2025, up from $3.6M at year-end 2024.","Operating cash burn reduced to $1.3M in Q1 2025 from $2.7M in Q1 2024.","Raised $5.0M via private placement in Feb 2025; warrants may add $5.0M at $3.32/share.","Sold non-core subsidiary TA&T, shut down Armor subsidiary; negotiating lease reductions.","New Board appointments and long-term employment agreements with CEO and CIO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151916,"accession_number":"0001641172-25-009063","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SINTX Technologies signs new 2-year exec agreements with CEO Olson and CIO Honigblum","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Eric Olson receives $375,000 annual base salary and 40% target bonus; CIO Gregg Honigblum receives $325,000 and 35% target bonus.","Agreements have 2-year term with automatic renewal; severance of 12 months' base salary for termination without cause or for good reason.","Change-in-control triggers payment of 3x (base salary + target bonus), pro-rated bonus, and 36 months of health coverage.","Company will provide gross-up payment for any excise tax under Section 4999 of the Internal Revenue Code."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151915,"accession_number":"0001641172-25-003233","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-04-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SINTX Technologies appoints five new directors; five resign, effective April 3, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Jay M. Moyes (Audit Chair), Robert D. Mitchell (Nominating & Governance Chair), Mark Anderson (Compensation Chair), Chris Lyons, and Gregg Honigblum (also CSO).","Resigned directors B. Sonny Bal, David Truetzel, Jeffrey White, Eric Stookey, and Mark Froimson; resignations not due to any disagreement.","New directors bring medtech, biotech, and finance expertise; non-employee directors compensated per prior plan; Honigblum receives no additional pay.","Former committee chairs Truetzel, White, Stookey replaced by Moyes, Mitchell, and Anderson respectively."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170773,"accession_number":"0001493152-25-010204","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-03-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Eric K. Olson appointed Chairman of SINTX Technologies, replacing B. Sonny Bal","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric K. Olson appointed Chairman of the Board effective March 7, 2025.","B. Sonny Bal stepped down as Chairman but continues as a Board member.","Olson previously joined the Board on July 31, 2024 and remains CEO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170772,"accession_number":"0001493152-25-008277","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-02-26T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"SINTX raises $5M in private placement at $3.45/sh with warrants exercisable at $3.32","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $5.0M from sale of 1,449,287 shares/pre-funded warrants at $3.45 each.","Issued warrants to purchase up to 1,449,287 shares at $3.32, exercisable immediately for 5.5 years.","Private placement closed on February 25, 2025; net proceeds for working capital.","H.C. Wainwright acted as exclusive placement agent; fees include 7.5% cash commission and warrants.","Registration rights granted to file resale registration statement within 30 days of closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170771,"accession_number":"0001493152-25-007635","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Sintx sells wholly owned subsidiary TA&T to Tethon for liability assumption","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Sold all shares of Technology Assessment and Transfer, Inc. to Tethon Corporation on Feb 19, 2025.","Consideration consists solely of Tethon assuming outstanding liabilities of TA&T; no cash involved.","Agreement includes customary representations, warranties, covenants, and indemnities.","Transaction effective immediately; TA&T is no longer a consolidated subsidiary of Sintx."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187751,"accession_number":"0001493152-24-051827","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SINTX shareholders elect director, ratify auditor, approve equity plan amendment at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class I director Mark Froimson (MD) elected with 65,138 votes for, 11,650 withheld; 375,417 broker non-votes.","Ratification of Tanner LLC as independent auditor for FY2024 passed with 418,120 for, 18,452 against.","Non-binding advisory vote on executive compensation adopted (45,812 for; 26,817 against).","Amendment to 2020 Equity Incentive Plan approved, increasing authorized shares by 333,650 (44,811 for; 29,253 against).","Adjournment proposal approved (363,474 for; 85,363 against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187750,"accession_number":"0001493152-24-049998","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-12-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SINTX ups CEO Olson's severance to 2x salary, adds CSO Honigblum change-of-control deal","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CEO Eric Olson's severance multiplier raised from 1x to 2x highest annual salary in prior three years.","CSO Gregg Honigblum gets new Change of Control Agreement with 2x salary severance plus 12 months health coverage.","Both agreements provide full equity vesting upon change in control and gross-up for excise taxes under Section 4999.","Changes effective December 12, 2024; Olson's amendment and Honigblum's new agreement detailed in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187749,"accession_number":"0001493152-24-048140","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-11-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CEO Eric K. Olson appointed to SINTX Board of Directors effective Nov 22, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric K. Olson, CEO and President since August 2024, appointed to the Board of Directors.","Appointment effective November 22, 2024; no additional compensation for board service.","No family relationships or material transactions with the company disclosed.","Previously served as SINTX CEO (2012-2014) and as CEO of Foresite Innovations and Predictive Biotech."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187748,"accession_number":"0001493152-24-046863","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"SINTX appoints Gregg Honigblum as Chief Strategy Officer; 6-month term, $137,500 base salary","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gregg Honigblum appointed CSO effective Nov 15, 2024; previously Managing Director at FNEX Capital.","Employment agreement: 6-month term, $137,500 base salary, eligible for bonuses and equity awards.","Severance if terminated without cause: base salary for longer of 3 months or remainder of term.","Honigblum has over 35 years experience in healthcare and investment banking; raised over $500M.","Instrumental in early-stage capital for Myriad Genetics and early investor in Acacia Biosciences."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187747,"accession_number":"0001493152-24-046415","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"SINTX Technologies Announces Stock Repurchase Program of Up to $500,000","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $500,000 in common stock, representing about 20% of outstanding shares.","Repurchase program managed by Maxim Group, LLC and may be suspended or discontinued at any time.","CEO Eric Olson stated the program reflects confidence in strategic initiatives and commitment to shareholder value.","Repurchases may be conducted via open market, block trades, accelerated transactions, or Rule 10b5-1 plans."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187746,"accession_number":"0001493152-24-043336","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SINTX Technologies amends CEO employment agreement, extends term to 12 months and adds change of control provisions","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Eric K. Olson's employment term extended from 6 to 12 months, with automatic 6-month renewals unless notice given.","New Change of Control Agreement provides for full vesting of all outstanding options, restricted stock, and other equity upon change of control.","Severance after change of control: lump sum equal to 1x highest annual salary including bonuses over prior 3 years, plus 12 months health coverage.","Change of control defined as 50% voting power acquisition, merger, asset sale, or board composition change not approved.","Gross-up provision for excise tax under Section 4999 if severance payments exceed limits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204251,"accession_number":"0001493152-24-038318","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-09-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"SINTX Technologies enters employment agreement with CEO Eric K. Olson","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Six-month term, auto-renewed for six-month periods unless 30 days' notice.","Mr. Olson receives a $25,000 cash bonus upon execution of the agreement.","Annual base salary of $350,000; eligible for annual bonuses and equity awards.","Severance without cause/good reason: up to 3 months' salary (or remainder of term) or 12 months if within 3 months of change in control.","Severance conditioned on execution of a general release of claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204250,"accession_number":"0001493152-24-030376","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"SINTX appoints Eric K. Olson as CEO and President effective August 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Eric K. Olson named CEO and President, succeeding B. Sonny Bal who retired as CEO and becomes Chairman.","Olson previously served as CEO of SINTX from 2012-2014 and led its 2014 IPO.","Gregg Honigblum designated as Board Advisor; he previously raised private equity for SINTX and served on its board.","Olson most recently was Founder/CEO of Foresite Innovations; has over 30 years in medical device and biomaterials.","No family relationships or material transactions between Olson and the Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":204249,"accession_number":"0001493152-24-026966","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-07-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SINTX Technologies Resumes At-the-Market Equity Offering of Up to $3.1 Million","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company terminated previous ATM sales on March 22, 2024, after raising $15M under original agreement.","New offering registered under Form S-3 with Maxim Group LLC as sales agent.","Proceeds to be used primarily for working capital and general corporate purposes; amount not yet determinable.","Shares sold will be common stock with no minimum offering requirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220987,"accession_number":"0001493152-24-023552","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-06-12T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SINTX regains Nasdaq minimum bid price compliance; one-year monitoring period begins","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received Nasdaq notice on June 11, 2024 confirming compliance with $1.00 bid price rule.","Previously announced delisting issue resolved; company placed under Mandatory Panel Monitor for one year.","If closing bid falls below $1.00 for 30 consecutive days within the year, Nasdaq will issue delist determination without grace period.","Company retains right to request a new hearing if a deficiency occurs.","Manufactures advanced ceramic materials; trading symbol SINT on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220986,"accession_number":"0001493152-24-021101","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["3.03","5.03","8.01","9.01"],"status":"ready","headline":"SINTX announces 1-for-200 reverse stock split effective May 28, 2024 to meet Nasdaq bid price rule","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at 1-for-200 ratio effective May 28, 2024 at 12:01 a.m. ET.","Outstanding shares will reduce from ~123 million to ~0.6 million; fractional shares rounded up.","Primary intent is to regain compliance with Nasdaq minimum bid price requirement.","CUSIP changes to 829392703; stock continues trading under symbol 'SINT' on split-adjusted basis."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220985,"accession_number":"0001493152-24-019556","cik":1269026,"company_name":"Sintx Technologies, Inc.","ticker":"SINT","form_type":"8-K","filed_at":"2024-05-15T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SINTX shareholders approve reverse stock split at ratio 1:100 to 1:300","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special meeting held May 14, 2024; quorum of 24,134,268 shares present.","Proposal 1 (reverse split) approved: 20.7M for, 3.3M against, 150K abstain.","Board authorized to implement split at any ratio from 1:100 to 1:300 within 12 months.","Adjournment proposal also passed but not needed due to approval of Proposal 1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":9761569.641921395,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}